Pipeline

Product / PlatformDiscoveryPre‑clinicalPhase 1
Pain (Post-Operative) / Fixed Dose

Pre-filled syringe of local anesthetic formulation for sustained post-surgical pain relief

Oncology (solid tumours) / Fixed Dose

Pre-filled syringe of anti-neoplastic agent for local management of solid tumours with reduced systemic toxicity

  
Anti-Infectives (surgical) / Fixed Dose

Pre-filled syringe of antibiotics for prophylaxis and local management of surgical site infections

  
Other (incl. Derm) / Fixed Dose
  
Oncology (solid tumours) / Fixed Dose Combo

Local delivery of multimodal synergistic small molecule and/or monoclonal antibody combinations for solid tumour management with reduced systemic toxicity

  
Anti-Infectives (surgical) / Fixed Dose Combo

Pre-filled syringe of synergistic antibiotic combinations for prophylaxis and local management of surgical site infections

  
Oncology (solid tumours) / Smart Materials

Locally activated biologic therapy for improved efficacy and reduced systemic toxicity

  

Platform

Fixed Dose
High dose, localized depot for days to weeks therapeutic delivery

Fixed Dose Combo

Combinations of small molecules and biologics in a localized depot for days to months delivery

Smart Materials

Local depot to concentrate, sequester or activate and release drug based on physiological signals

Hydrogel
Amacathera Logo

AmacaThera is a clinical-stage biotechnology company transforming therapeutics to make a difference in patient health. Our unique, injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes across multiple therapeutic areas, including post‑surgical pain management, cancer and other hard‑to‑reach target areas.